Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A26480 | 20413174 | J Hepatol | Maternal obesity during pregnancy and lactation programs the development of offspring non-alcoholic fatty liver disease in mice. | 2010 | Details |
| A26481 | 20412588 | BMC Gastroenterol | Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest). | 2010 | Details |
| A26482 | 20412325 | Hepatol Res | Measurement of spleen volume is useful for distinguishing between simple steatosis and early-stage non-alcoholic steatohepatitis. | 2010 | Details |
| A26483 | 20388946 | J Physiol Pharmacol | Therapy of nonalcoholic fatty liver disease: current status. | 2009 | Details |
| A26484 | 20407889 | Osteoporos Int | Zoledronic acid-induced transient hepatotoxicity in a patient effectively treated for Paget's disease of bone. | 2010 | Details |
| A26485 | 20407430 | Am J Gastroenterol | A role for low hepatic copper concentrations in nonalcoholic Fatty liver disease. | 2010 | Details |
| A26486 | 20406065 | Biomark Med | Is alanine aminotransferase level a surrogate biomarker of hepatic apoptosis in nonalcoholic fatty liver disease? | 2010 | Details |
| A26487 | 20403043 | Pathol Int | Nuclear size measurement is a simple method for the assessment of hepatocellular aging in non-alcoholic fatty liver disease: Comparison with telomere-specific quantitative FISH and p21 immunohistochemistry. | 2010 | Details |
| A26488 | 20402835 | J Dig Dis | Dynamic expression of hepatic thioredoxin mRNA in rats with non-alcoholic fatty liver disease. | 2010 | Details |
| A26489 | 20402293 | Coll Antropol | Predictors of nonalcoholic steatohepatitis in patients with elevated alanine aminotransferase activity. | 2010 | Details |
| A26490 | 20400911 | J Pediatr Gastroenterol Nutr | Endotoxin and plasminogen activator inhibitor-1 serum levels associated with nonalcoholic steatohepatitis in children. | 2010 | Details |
| A26491 | 20399157 | Dig Liver Dis | Comparison of simplified score with the revised original score for the diagnosis of autoimmune hepatitis: a new or a complementary diagnostic score? | 2010 | Details |
| A26492 | 20398952 | Arch Gerontol Geriatr | Hepatic steatosis: an experimental model for quantification. | 2010 | Details |
| A26493 | 20398645 | Clin Biochem | Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes. | 2010 | Details |
| A26494 | 20398192 | Pathol Int | Clinicopathological correlations in a series of adult patients with non-alcoholic fatty liver disease. | 2010 | Details |
| A26495 | 20394204 | Vnitr Lek | [Prevalence of liver disease markers among patients with metabolic risk factors]. | 2010 | Details |
| A26496 | 20392873 | J Clin Endocrinol Metab | Intracellular nicotinamide phosphoribosyltransferase protects against hepatocyte apoptosis and is down-regulated in nonalcoholic fatty liver disease. | 2010 | Details |
| A26497 | 20392616 | Nutr Metab Cardiovasc Dis | Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease. | 2010 | Details |
| A26499 | 20392512 | J Hepatol | Involvement of microsomal triglyceride transfer protein in nonalcoholic steatohepatitis in novel spontaneous mouse model. | 2010 | Details |
| A26500 | 20391243 | Res Sports Med | Medical consequences of childhood obesity: a Hong Kong perspective. | 2010 | Details |
| A26501 | 20388146 | Ann N Y Acad Sci | The traditional Japanese formula keishibukuryogan reduces liver injury and inflammation in patients with nonalcoholic fatty liver disease. | 2010 | Details |
| A26502 | 20388084 | Curr Pharm Des | Hepatocellular carcinoma and non-alcoholic fatty liver disease: from a clinical to a molecular association. | 2010 | Details |
| A26503 | 20387643 | Ukr Biokhim Zh (1999) | Nonalcoholic fatty liver disease: biochemical and therapeutic considerations. | 2010 | Details |
| A26504 | 20385813 | Proc Natl Acad Sci U S A | A feed-forward loop amplifies nutritional regulation of PNPLA3. | 2010 | Details |
| A26506 | 20384692 | J Eur Acad Dermatol Venereol | Exploring the association between cardiovascular and other disease-related risk factors in the psoriasis population: the need for increased understanding across the medical community. | 2010 | Details |
| A26507 | 20379797 | Obes Surg | The decrease of serum levels of human neutrophil alpha-defensins parallels with the surgery-induced amelioration of NASH in obesity. | 2010 | Details |
| A26509 | 20375640 | Korean J Hepatol | [Validity and reliability of the nonalcoholic fatty liver diseases activity score (NAS) in Korean NAFLD patients and its correlation with clinical factors]. | 2010 | Details |
| A26510 | 20373368 | Hepatology | Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. | 2010 | Details |
| A26511 | 20373005 | J Bioenerg Biomembr | Effects of a high fat diet on liver mitochondria: increased ATP-sensitive K+ channel activity and reactive oxygen species generation. | 2010 | Details |
| A26512 | 20372110 | Am J Gastroenterol | Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease. | 2010 | Details |
| A26513 | 20371430 | Adv Med Sci | Tumor necrosis factor alpha and its soluble receptors in obese children with NAFLD. | 2010 | Details |
| A26514 | 20370930 | J Med Case Rep | Hepatoprotective effects of Spirulina maxima in patients with non-alcoholic fatty liver disease: a case series. | 2010 | Details |
| A26515 | 20370732 | J Gastroenterol Hepatol | Electron microscopic findings in non-alcoholic fatty liver disease: is there a difference between hepatosteatosis and steatohepatitis? | 2010 | Details |
| A26516 | 20370678 | Curr Pharm Des | Adipocytokines in nonalcoholic fatty liver disease: key players regulating steatosis, inflammation and fibrosis. | 2010 | Details |
| A26517 | 20370677 | Curr Pharm Des | Insulin resistance in nonalcoholic fatty liver disease. | 2010 | Details |
| A26518 | 20370676 | Curr Pharm Des | Leptin: the prototypic adipocytokine and its role in NAFLD. | 2010 | Details |
| A26519 | 20370674 | Curr Pharm Des | Role of microRNAs in non-alcoholic steatohepatitis. | 2010 | Details |
| A26520 | 20370672 | Curr Pharm Des | Pre-B cell colony enhancing factor/NAMPT/visfatin in inflammation and obesity-related disorders. | 2010 | Details |
| A26521 | 20370671 | Curr Pharm Des | Current and future therapeutic strategies in NAFLD. | 2010 | Details |
| A26522 | 20370670 | Curr Pharm Des | Retinol-binding protein 4 and new adipocytokines in nonalcoholic fatty liver disease. | 2010 | Details |
| A26523 | 20369224 | Diabetologia | Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients. | 2010 | Details |
| A26524 | 20368747 | Clin Lipidol | Mechanisms and clinical implications of hepatocyte lipoapoptosis. | 2010 | Details |
| A26525 | 20368739 | Nat Rev Gastroenterol Hepatol | The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. | 2010 | Details |
| A26526 | 20037278 | Korean J Hepatol | Current status of liver disease in Korea: nonalcoholic fatty liver disease. | 2009 | Details |
| A26527 | 20361370 | Chirurg | [Indications and principles of metabolic surgery]. | 2010 | Details |
| A26528 | 20357081 | J Nutr | Intake of trans fatty acids causes nonalcoholic steatohepatitis and reduces adipose tissue fat content. | 2010 | Details |
| A26529 | 20355234 | World J Gastroenterol | Liver fat content determined by magnetic resonance imaging and spectroscopy. | 2010 | Details |
| A26530 | 20355232 | World J Gastroenterol | Ezetimbe as potential treatment for cholesterol gallstones: the need for clinical trials. | 2010 | Details |
| A26531 | 20353583 | J Inflamm (Lond) | Elevated endotoxin levels in non-alcoholic fatty liver disease. | 2010 | Details |
| A26532 | 20352596 | Z Gastroenterol | [Histopathological diagnose of non-alcoholic and alcoholic fatty liver disease]. | 2010 | Details |
| A26533 | 20347174 | J Hepatol | Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model. | 2010 | Details |
| A26534 | 20308723 | Ann Hepatol | High ghrelin and obestatin levels and low risk of developing fatty liver. | 2010 | Details |
| A26535 | 20305757 | Hepatol Int | Fatty liver disease in children: eat now pay later. | 2010 | Details |
| A26537 | 20303728 | J Nutr Biochem | Integrated hepatic transcriptome and proteome analysis of mice with high-fat diet-induced nonalcoholic fatty liver disease. | 2010 | Details |
| A26538 | 20303351 | Gastroenterology | Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia. | 2010 | Details |
| A26539 | 20301112 | Hepatology | Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. | 2010 | Details |
| A26540 | 20300479 | Mediators Inflamm | Inflammatory mediators of hepatic steatosis. | 2010 | Details |
| A26541 | 20299294 | Prim Care Diabetes | Non-Alcoholic Fatty Liver Disease (NAFLD): new challenge for general practitioners and important burden for health authorities? | 2010 | Details |
| A26542 | 20298493 | Acta Paediatr | Metabolic differences between male and female adolescents with non-alcoholic fatty liver disease, as detected by ultrasound. | 2010 | Details |
| A26543 | 20236931 | J Biol Chem | Thyroid hormone regulates hepatic expression of fibroblast growth factor 21 in a PPARalpha-dependent manner. | 2010 | Details |
| A26544 | 20235368 | Acta Med Croatica | [Ultrasonography in the diagnosis of nonalcoholic fatty liver disease]. | 2009 | Details |
| A26545 | 20231283 | J Biol Chem | Inhibition of acyl-coenzyme A:cholesterol acyltransferase 2 (ACAT2) prevents dietary cholesterol-associated steatosis by enhancing hepatic triglyceride mobilization. | 2010 | Details |
| A26546 | 20227267 | Prostaglandins Leukot Essent Fatty Acids | Regulation of hepatic gene expression by saturated fatty acids. | 2010 | Details |
| A26547 | 20227260 | Nutr Metab Cardiovasc Dis | Endothelial dysfunction and non-alcoholic liver steatosis in hypertensive patients. | 2010 | Details |
| A26548 | 20226139 | Zhong Xi Yi Jie He Xue Bao | [Pathogenesis and treatment of non-alcoholic fatty liver disease]. | 2010 | Details |
| A26549 | 20222991 | Lipids Health Dis | NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease. | 2010 | Details |
| A26550 | 20222159 | World J Gastroenterol | Steatosis as a co-factor in chronic liver diseases. | 2010 | Details |
| A26551 | 20221762 | Pathologe | [Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease. Grade 2 consensus-based guidelines]. | 2010 | Details |
| A26552 | 20221393 | PLoS One | Role of alcohol metabolism in non-alcoholic steatohepatitis. | 2010 | Details |
| A26553 | 20216561 | Eur J Clin Nutr | Dietary and physical activity patterns in children with fatty liver. | 2010 | Details |
| A26554 | 20216079 | J Clin Gastroenterol | An epidemiologic study on the incidence and significance of HFE mutations in a Korean cohort with nonalcoholic fatty liver disease. | 2010 | Details |
| A26556 | 20210788 | Basic Clin Pharmacol Toxicol | Hepatic effects of rosiglitazone in rats with the metabolic syndrome. | 2010 | Details |
| A26557 | 20207596 | Dig Liver Dis | From the metabolic syndrome to NAFLD or vice versa? | 2010 | Details |
| A26558 | 20206411 | Gastroenterol Hepatol | [Obesity and liver disease]. | 2010 | Details |
| A26559 | 20206399 | J Hepatol | Impaired liver regeneration of steatotic rats after portal vein ligation: a particular emphasis on (99m)Tc-DISIDA scintigraphy and adiponectin signaling. | 2010 | Details |
| A26560 | 20204774 | Adv Exp Med Biol | Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, improves hepatic microcirculatory patency and oxygen availability in a high-fat-diet-induced fatty liver in mice. | 2010 | Details |
| A26561 | 20204561 | AAPS J | Role of cannabinoids in the development of fatty liver (steatosis). | 2010 | Details |
| A26562 | 20203644 | Am J Gastroenterol | Diabetes and hepatocellular carcinoma: what role does diabetes have in the presence of other known risk factors? | 2010 | Details |
| A26563 | 20203643 | Am J Gastroenterol | Non-alcoholic fatty liver disease after liver transplantation: a case of nurture and nature. | 2010 | Details |
| A26564 | 20203061 | Am J Physiol Gastrointest Liver Physiol | Betaine improved adipose tissue function in mice fed a high-fat diet: a mechanism for hepatoprotective effect of betaine in nonalcoholic fatty liver disease. | 2010 | Details |
| A26565 | 20200515 | Clin Pharmacol Ther | Nuclear receptors, inflammation, and liver disease: insights for cholestatic and fatty liver diseases. | 2010 | Details |
| A26566 | 20196952 | Zhonghua Gan Zang Bing Za Zhi | [Involvement of endoplasmic reticulum stress in development of fatty liver fibrosis induced by methionine-choline-deficient diet in rats]. | 2010 | Details |
| A26567 | 20196730 | Curr Mol Med | Non-invasive diagnostic tests for non-alcoholic fatty liver disease. | 2010 | Details |
| A26568 | 20195647 | J Gastroenterol | Impaired dendritic cell functions disrupt antigen-specific adaptive immune responses in mice with nonalcoholic fatty liver disease. | 2010 | Details |
| A26569 | 20195271 | Nat Rev Gastroenterol Hepatol | Pathology of nonalcoholic fatty liver disease. | 2010 | Details |
| A26570 | 20195231 | Panminerva Med | Metabolic syndrome and liver transplantation. | 2009 | Details |
| A26571 | 20189787 | Prostaglandins Leukot Essent Fatty Acids | Fatty liver: role of inflammation and fatty acid nutrition. | 2010 | Details |
| A26572 | 20188144 | Biochim Biophys Acta | Selenium supplementation attenuates procollagen-1 and interleukin-8 production in fat-loaded human C3A hepatoblastoma cells treated with TGFbeta1. | 2010 | Details |
| A26573 | 20186137 | Obesity (Silver Spring) | Effects of metformin and weight loss on serum alanine aminotransferase activity in the diabetes prevention program. | 2010 | Details |
| A26574 | 20185414 | J Lipid Res | Dietary fatty acids modulate antigen presentation to hepatic NKT cells in nonalcoholic fatty liver disease. | 2010 | Details |
| A26575 | 20182586 | Am J Transl Res | Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells. | 2010 | Details |
| A26576 | 20181335 | Atherosclerosis | Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: association with liver fibrosis. | 2010 | Details |
| A26577 | 20179669 | Int J Obes (Lond) | Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study. | 2010 | Details |
| A26578 | 20176643 | Gut | Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease. | 2010 | Details |
| A26579 | 20175770 | Aliment Pharmacol Ther | Clinical predictors of fibrosis in patients with chronic liver disease. | 2010 | Details |
| A26580 | 20171943 | Dig Liver Dis | Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. | 2010 | Details |
| A26581 | 20170634 | Biochem Biophys Res Commun | Maternal obesity programmes offspring development of non-alcoholic fatty pancreas disease. | 2010 | Details |
| A26582 | 20168226 | Curr Opin Gastroenterol | Recent advances in nonalcoholic fatty liver disease. | 2010 | Details |
| A26583 | 20165979 | Dig Dis Sci | Protective role of coffee in non-alcoholic fatty liver disease (NAFLD). | 2010 | Details |
| A26584 | 20164781 | Eur J Gastroenterol Hepatol | The role of nutritional profile in the orexigenic neuropeptide secretion in nonalcoholic fatty liver disease obese adolescents. | 2010 | Details |